Diabetic in Volgograd Went Three Months Without Subsidized Medications

The daughter of a 78-year-old Volgograd resident suffering from diabetes reported systematic failures in the provision of subsidized medications. For three months, the necessary drugs had to be purchased by the family themselves.
«My mother receives subsidized medication for diabetes. In 2025, a prescription for free receipt of the drug »Onglyza« was issued on 14 October 2025. This drug was not provided to my mother until the end of 2025,» says the daughter of the patient, who is attached to Clinic No. 7 in the Sovetsky District. «On 14 January 2026, this prescription was replaced with a new one, although during the time we were at the doctor that day and issuing prescriptions, including redoing the prescription for a new drug, the old drug arrived at the pharmacy. But since the prescription was redone, they said: receive it with the new one, since it came, and come back in a week, we»ll issue a prescription for «Onglyza» for January. On 23 January 2026, my mother was told that in January she had already processed a prescription for this drug. And the fact that for three months we bought it with our own money doesn«t concern them… The chaos with the issuance of subsidized drugs is complete.»
«One pack of this drug costs about 2000 rubles (approximately $20 at current rates). We bought it twice for sure. We also purchased »Forxiga« for 2200 rubles (approximately $22 at current rates), and this drug was also not issued for a long time. The regional health committee responded: you can get back 13% of the spent funds through the tax office. We already know that…»
Now the woman is receiving medication under a new prescription. However, the family wants to find out if the spent money will be compensated. This issue and the general situation with subsidized provision are being investigated by the regional health committee.
Earlier, in the Svetlyarsky district of Volgograd Oblast, a 52-year-old patient with cancer was also unable to timely receive a subsidized drug for chemotherapy. According to her daughter, these tablets were not available in the pharmacy for more than three weeks, leading to a forced break in treatment. The regional health department reported that the medication would arrive within three days and would contact the patient.




